Citation sources

Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
9	10	Search

2025	Effects of empagliflozin and its combination with docetaxel on LNCaP and DU- 145 prostate cancer cell lines: cytotoxicity and molecular pathway analysis Naunyn-Schmiedeberg's Archives of Pharmacology Ahmet Cumaoğlu, Selda Nur Akdeniz, Ahmad Karzoon, Mohamed Alaama, Mükerrem Betül Yerer
2023	Synthesis and clinical application of small-molecule drugs approved to treat prostatic cancer European Journal of Medicinal Chemistry Jing-Yi Zhang, Li-Jie Zhao, Ya-Tao Wang
2023	Unlocking the synthetic approaches and clinical application of approved small-molecule drugs for gastrointestinal cancer treatment: A comprehensive exploration European Journal of Medicinal Chemistry Xiao-Jing Li, Peng Nie, Piet Herdewijn, Jian-Gang Sun
2022	Cross-Talk between Wnt Signaling and Src Tyrosine Kinase Biomedicines Jung Ki Min, Hwee-Seon Park, Yoon-Beom Lee, Jae-Gyu Kim, Jong-Il Kim, Jae-Bong Park
2021	Docetaxel and Lidocaine Co-Loaded (NLC-in-Hydrogel) Hybrid System Designed for the Treatment of Melanoma Pharmaceutics Ludmilla David de Moura, Lígia N. M. Ribeiro, Fabíola V. de Carvalho, Gustavo H. Rodrigues da Silva, Priscila C. Lima Fernandes, Sérgio Q. Brunetto, Celso D. Ramos, Lício A. Velloso, Daniele R. de Araújo, Eneida de Paula
2021	An in vitro cytotoxicity of glufosfamide in HepG2 cells relative to its nonconjugated counterpart Journal of the Egyptian National Cancer Institute Doaa E. Ahmed, Fatma B. Rashidi, Heba K. Abdelhakim, Amr S. Mohamed, Hossam M. M. Arafa
2020	Docetaxel/cabazitaxel and fatty acid binding protein 5 inhibitors produce synergistic inhibition of prostate cancer growth The Prostate Gregory Carbonetti, Cynthia Converso, Timothy Clement, Changwei Wang, Lloyd C Trotman, Iwao Ojima, Martin Kaczocha
2018	Prazosin but Not Tamsulosin Sensitises PC-3 and LNCaP Prostate Cancer Cells to Docetaxel Pharmacology Briohny H. Spencer, Catherine M. McDermott, Russ Chess-Williams, David Christie, Shailendra Anoopkumar-Dukie
2018	Clathrin-mediated endocytic uptake of PUFA enriched self-nanoemulsifying lipidic systems (SNELS) of an anticancer drug against triple negative cancer and DMBA induced preclinical tumor model Materials Science and Engineering: C Rajneet Kaur Khurana, Rajendra Kumar, Balan Louis Gaspar, Gail Welsby, Philip Welsby, Prashant Kesharwani, O.P. Katare, Kamalinder K. Singh, Bhupinder Singh
	Additional cited-by details will be shown when available from Crossref